Stocks Consumer discretionary EVH
NYSE · Consumer discretionaryEvolent Health, Inc. (EVH)
Evolent Health, Inc. brought in $2.1B of revenue over the twelve months to June 30, 2026, down 4.5% from a year earlier. It posted a net loss of $505M. At June 30, 2026 it held $115.7M in cash against $966.5M of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 6, 2026.
What Evolent Health, Inc. does
Evolent Health, Inc. is registered with the SEC under industry code SIC 8741 (Services-Management Services). Its shares trade on NYSE under the ticker EVH.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $1.9B | -$534.5M | -$5.07 | n/a |
| 2024 | $2.6B | -$61.6M | -$0.81 | n/a |
| 2023 | $2B | -$113M | -$1.28 | n/a |
| 2022 | $1.4B | -$19.2M | -$0.20 | n/a |
| 2021 | $908M | -$37.6M | -$0.44 | n/a |
| 2020 | $924.6M | -$334.2M | -$3.94 | n/a |
Latest SEC filings
What Evolent Health, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 8, 2026Passive stake changed SCHEDULE 13G/A
- August 6, 2026Quarterly report 10-Q · period to June 30, 2026
- August 6, 2026
- July 17, 2026Passive stake (5% or more) SCHEDULE 13G
- June 10, 2026
- June 4, 2026
- May 7, 2026Quarterly report 10-Q · period to March 31, 2026
- May 7, 2026
- April 24, 2026
- April 24, 2026Additional proxy material DEFA14A
Questions about EVH
What does Evolent Health, Inc. do?
Evolent Health, Inc. is registered with the SEC under industry code SIC 8741 (Services-Management Services). Its shares trade on NYSE under the ticker EVH.
Is Evolent Health, Inc. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $505M on revenue of $2.1B.
How much revenue does Evolent Health, Inc. make?
Over the twelve months to June 30, 2026 Evolent Health, Inc. reported revenue of $2.1B. That is 4.5% less than a year earlier.
When did Evolent Health, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 6, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the passive stake changed from September 8, 2026.
Similar companies
Follow EVH
Get an email when Evolent Health, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Follow EVH: get an email when it filesWhere the numbers come from
Financial figures are the values Evolent Health, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.